Literature DB >> 21615333

Super toxins from a super bug: structure and function of Clostridium difficile toxins.

Abigail H Davies1, April K Roberts, Clifford C Shone, K Ravi Acharya.   

Abstract

Clostridium difficile, a highly infectious bacterium, is the leading cause of antibiotic-associated pseudomembranous colitis. In 2009, the number of death certificates mentioning C. difficile infection in the U.K. was estimated at 3933 with 44% of certificates recording infection as the underlying cause of death. A number of virulence factors facilitate its pathogenicity, among which are two potent exotoxins; Toxins A and B. Both are large monoglucosyltransferases that catalyse the glucosylation, and hence inactivation, of Rho-GTPases (small regulatory proteins of the eukaryote actin cell cytoskeleton), leading to disorganization of the cytoskeleton and cell death. The roles of Toxins A and B in the context of C. difficile infection is unknown. In addition to these exotoxins, some strains of C. difficile produce an unrelated ADP-ribosylating binary toxin. This toxin consists of two independently produced components: an enzymatic component (CDTa) and the other, the transport component (CDTb) which facilitates translocation of CDTa into target cells. CDTa irreversibly ADP-ribosylates G-actin in target cells, which disrupts the F-actin:G-actin equilibrium leading to cell rounding and cell death. In the present review we provide a summary of the current structural understanding of these toxins and discuss how it may be used to identify potential targets for specific drug design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615333     DOI: 10.1042/BJ20110106

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa.

Authors:  Alexander J Keeley; Nicholas J Beeching; Katharine E Stott; Paul Roberts; Alastair J Watson; Michael Bj Beadsworth
Journal:  Malawi Med J       Date:  2016-06       Impact factor: 0.875

2.  Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT).

Authors:  Carsten Schwan; Thilo Nölke; Anna S Kruppke; Daniel M Schubert; Alexander E Lang; Klaus Aktories
Journal:  J Biol Chem       Date:  2011-06-25       Impact factor: 5.157

3.  Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.

Authors:  Nader S Abutaleb; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

4.  Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.

Authors:  Tomohiko Murase; Luiz Eugenio; Melissa Schorr; Greg Hussack; Jamshid Tanha; Elena N Kitova; John S Klassen; Kenneth K S Ng
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 5.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

Review 6.  Clostridium difficile toxins: mediators of inflammation.

Authors:  Aimee Shen
Journal:  J Innate Immun       Date:  2012-01-10       Impact factor: 7.349

Review 7.  The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

Authors:  Xingmin Sun; Simon A Hirota
Journal:  Mol Immunol       Date:  2014-09-18       Impact factor: 4.407

8.  Cell-penetrating peptides derived from Clostridium difficile TcdB2 and a related large clostridial toxin.

Authors:  Jason L Larabee; Garrett D Hauck; Jimmy D Ballard
Journal:  J Biol Chem       Date:  2017-12-15       Impact factor: 5.157

9.  Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.

Authors:  Gabrielle Ripert; Silvia M Racedo; Anne-Marie Elie; Claudine Jacquot; Philippe Bressollier; Maria C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key.

Authors:  David B Stewart; Arthur Berg; John Hegarty
Journal:  J Gastrointest Surg       Date:  2012-10-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.